Tomsicek Michael John Insider Trades

Insider Trading History

Track insider trading activity for Tomsicek Michael John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $14.1k 9,366 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.5k 9,366 shares
$1.65
$1.51
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $30.6k 20,275 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.3k 20,275 shares
$1.20
$1.51
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $51.2k 40,000 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70k 40,000 shares
$1.75
$1.28
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $51.2k 40,000 shares
Last Trade
Aug 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58k 40,000 shares
$1.45
$1.28
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $30.6k 20,275 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 20,275 shares
$6.52
$1.51
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $38.4k 30,000 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116k 30,000 shares
$3.86
$1.28
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $53.2k 35,235 shares
Last Trade
Nov 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.51
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $19.2k 15,000 shares
Last Trade
Oct 19, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$79.8k 15,000 shares
$5.32
$1.28
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $38.4k 30,000 shares
Last Trade
Jul 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 30,000 shares
$6.07
$1.28
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $1.4M 26,891 shares
Last Trade
Aug 06, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.42M 25,000 shares
$136.74
$52.08
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $410k 7,880 shares
Last Trade
Aug 06, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.63M 19,011 shares
$138.22
$52.08
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $98.5k 1,891 shares
Last Trade
Aug 06, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$835k 5,989 shares
$139.46
$52.08
Milestone Pharmaceuticals
Milestone Pharmaceuticals MIST
Director
Holding Value $38.4k 30,000 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 30,000 shares
$5.54
$1.28
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $1.32M 25,360 shares
Last Trade
Mar 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.6M 34,360 shares
$133.88
$52.08
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $6.82M 131,000 shares
Last Trade
Mar 11, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.35M 25,000 shares
$133.88
$52.08
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $98.5k 1,891 shares
Last Trade
Mar 10, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$168k 1,352 shares
$124.15
$52.08
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $169k 3,243 shares
Last Trade
Mar 10, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$352k 2,833 shares
$124.15
$52.08
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $608k 11,666 shares
Last Trade
Oct 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 11,666 shares
$86.75
$52.08
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $8.12M 156,000 shares
Last Trade
Sep 01, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.12M 12,000 shares
$93.42
$52.08
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Financial Officer
Holding Value $646k 12,410 shares
Last Trade
Sep 01, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.12M 12,000 shares
$93.42
$52.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up